Multiple ways to kill bacteria via inhibiting novel cell wall or membrane targets.
Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA.
Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.
Purdue Institute of Inflammation, Immunology & Infectious Disease, Purdue University, West Lafayette, IN 47907, USA.
- Published Article
Future Medicinal Chemistry
"Future Science, LTD"
- Publication Date
Jul 01, 2020
The rise of antibiotic-resistant infections has been well documented and the need for novel antibiotics cannot be overemphasized. US FDA approved antibiotics target only a small fraction of bacterial cell wall or membrane components, well-validated antimicrobial targets. In this review, we highlight small molecules that inhibit relatively unexplored cell wall and membrane targets. Some of these targets include teichoic acids-related proteins (DltA, LtaS, TarG and TarO), lipid II, Mur family enzymes, components of LPS assembly (MsbA, LptA, LptB and LptD), penicillin-binding protein 2a in methicillin-resistant Staphylococcus aureus, outer membrane protein transport (such as LepB and BamA) and lipoprotein transport components (LspA, LolC, LolD and LolE). Inhibitors of SecA, cell division protein, FtsZ and compounds that kill persister cells via membrane targeting are also covered.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/18/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/32538147